rs200286768
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_139242.4(MTFMT):c.994C>T(p.Arg332*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000794 in 1,612,598 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_139242.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTFMT | ENST00000220058.9 | c.994C>T | p.Arg332* | stop_gained | Exon 9 of 9 | 1 | NM_139242.4 | ENSP00000220058.4 | ||
MTFMT | ENST00000558460.5 | n.994C>T | non_coding_transcript_exon_variant | Exon 9 of 10 | 5 | ENSP00000452646.1 | ||||
MTFMT | ENST00000560717.5 | n.*464C>T | non_coding_transcript_exon_variant | Exon 8 of 8 | 5 | ENSP00000457257.1 | ||||
MTFMT | ENST00000560717.5 | n.*464C>T | 3_prime_UTR_variant | Exon 8 of 8 | 5 | ENSP00000457257.1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152062Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000929 AC: 23AN: 247616Hom.: 0 AF XY: 0.0000967 AC XY: 13AN XY: 134390
GnomAD4 exome AF: 0.0000774 AC: 113AN: 1460536Hom.: 0 Cov.: 31 AF XY: 0.0000826 AC XY: 60AN XY: 726520
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152062Hom.: 0 Cov.: 31 AF XY: 0.000108 AC XY: 8AN XY: 74270
ClinVar
Submissions by phenotype
Combined oxidative phosphorylation defect type 15 Pathogenic:4
- -
ACMG classification criteria: PVS1 strong, PM2 supporting, PM3 strong -
This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PS1,PM2,PP3. -
Criteria applied: PVS1,PM3_VSTR -
not provided Pathogenic:2
Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 58 amino acids are lost, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (HGMD); This variant is associated with the following publications: (PMID: 34426522, 28058511, 22499348, 25058219, 23499752, 24461907, 27290639, 30369941, 31589614, 32577402, 32133637, 25911677, 31980526, 30911575) -
This sequence change creates a premature translational stop signal (p.Arg332*) in the MTFMT gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 58 amino acid(s) of the MTFMT protein. This variant is present in population databases (rs200286768, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with combined oxidative phosphorylation deficiency (PMID: 22499348, 23499752). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 39830). For these reasons, this variant has been classified as Pathogenic. -
MTFMT-Related Disorders Pathogenic:1
Variant summary: MTFMT c.994C>T (p.Arg332X) results in a premature termination codon in the last exon of the encoded protein, however, is not expected to undergo nonsense mediated decay. The variant allele was found at a frequency of 9.3e-05 in 247616 control chromosomes. c.994C>T has been reported in the literature in multiple homozygous and compound heterozygous individuals affected with MTFMT-Related Disorders (e.g. Hayhurst_2019). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 30911575). ClinVar contains an entry for this variant (Variation ID: 39830). Based on the evidence outlined above, the variant was classified as pathogenic. -
Inborn genetic diseases Pathogenic:1
The c.994C>T (p.R332*) alteration, located in exon 9 (coding exon 9) of the MTFMT gene, consists of a C to T substitution at nucleotide position 994. This changes the amino acid from an arginine (R) to a stop codon at amino acid position 332. This alteration occurs at the 3' terminus of the MTFMT gene, is not expected to trigger nonsense-mediated mRNA decay, and impacts the last 14.65% of the protein. Premature stop codons are typically deleterious in nature. This alteration has been reported in the homozygous and compound heterozygous states in multiple patients with mitochondrial methionyl-tRNA formyltransferase deficiency (Bennett, 2020; Haack, 2012; Haack, 2014; Neeve, 2013; Pronicka, 2016; Theunissen, 2018). Based on the available evidence, this alteration is classified as pathogenic. -
Mitochondrial complex 1 deficiency, nuclear type 27 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at